Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

Companies / Imbria Pharmaceuticals, Inc.

Imbria Pharmaceuticals, Inc.

Stage unknownBoston, MABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
1
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
1 rounds
  1. Mar 10, 2025
    Form D equity offering · $59.2M (form d sold) · 8 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “Imbria Pharmaceuticals, Inc. filed Form D: $59,195,818 sold of $124,195,815, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
2 officers, 9 directors
Timeline
2
  1. Dec 16, 2025
    Imbria Pharmaceuticals, Inc. filed Form D/A: $66,695,817 sold of $144,195,814, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Apr 1, 2025
    Imbria Pharmaceuticals, Inc. filed Form D: $59,195,818 sold of $124,195,815, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company